Adalimumab & Adalimumab Ab panel:-:Pt:Ser/Plas:-:IA

Preferred Label : Adalimumab & Adalimumab Ab panel:-:Pt:Ser/Plas:-:IA;

LOINC status : ACTIVE;

LOINC display name : Adalimumab and Adalimumab Ab panel IA;

LOINC long common name : Adalimumab and Adalimumab Ab panel - Serum or Plasma by Immunoassay;

LOINC short name : Adalimumab Adalimumab Ab Pnl SerPl IA;

Details

Origin ID

99781-7;

UMLS CUI

C5570402;

Has component
- Adalimumab [LOINC component]
- Adalimumab Ab [LOINC component]
- Adalimumab and Adalimumab Ab panel [LOINC component]
Has method
- Immunoassay [LOINC method]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Panel of LOINC codes
- Adalimumab Ab:MCnc:Pt:Ser/Plas:Qn: [LOINC code]
- Adalimumab:MCnc:Pt:Ser/Plas:Qn: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients